All News

Making the store’s front end a priority can increase revenue opportunities and boost pharmacy profit.

In case you missed it, this week we had stories about the FDA approval of Pfizer's RSV vaccine, vaccines and COVID-19 hospitalization in children, race-based disparities in multimodal analgesia, and more.

The Drug Enforcement Administration gives controlled substance licenses, and can just as easily take them away.

The first of a 2-part presentation focused on vaccines for COVID-19, flu, RSV, and pneumococcal disease.

The FDA has approved just the second treatment for uncomplicated urinary tract infections (UTIs) in the last 2 decades.

The cost effectiveness of biosimilar denosumab for postmenopausal osteoporosis varies significantly based on factors like adherence, subsequent therapies, and treatment duration.

As the H5 bird flu outbreak gradually impacts human health in the US, health care experts weighed in on possibilities of a future vaccine.

A series of posters presented at AMCP Nexus 2024 highlighted the evolving landscape of women's health, focusing on the use of medications for preterm birth prevention and the adoption of telehealth for prenatal consultations.

A recent study found the percentage of type 1 diabetes patients who were prescribed either GLP-1s or SGLT2 inhibitors increased from 0.7% to 8.3% between 2010 and 2023.

Adding to the mail-order options within big chain pharmacy, Walmart is promising prescription delivery in as quickly as 30 minutes.

Researchers addressed the association between sleep patterns and digestive diseases, as well as patients’ genetic likeliness of developing future digestive complications.

A study found that children aged 6 months or younger who are not eligible for vaccination were at the highest risk for hospitalization due to SARS-CoV-2.

In a comprehensive literature review, researchers addressed the impact cardiac surgery has on gastrointestinal outcomes.

Abrysvo is the only RSV vaccine approved for use in this age group.

Investigators conducted a study to assess the impact of combined diet and exercise interventions in patients with type 2 diabetes.

Results of the SOUL clinical trial will be presented at a scientific meeting in 2025.

Analyzing copayments and coverage plans for popular weight-loss drugs in the US, researchers addressed the cost-effectiveness of GLP-1 medications for treating obesity.

Opioid use disorder risk was higher in a cohort of patients with chronic pain without disability.

Researchers explored the stigmatization of sexually transmitted infections across film while also identifying inaccuracies in STI-related content on Tik Tok.

Multimodal analgesia provides more effective pain management—and leads to a decrease in opioid use.

Pharmacist education can positively impact patient counseling around vaccinations in older adults.

Suzetrigine could represent the first new nonopioid drug in a distinct class of pain medications in approximately 20 years.

Normalizing conversations around mental health in older adult populations can improve outcomes.

A conversation with Rakesh Jain, MD, MPH, clinical professor in the Department of Psychiatry at Texas Tech University School of Medicine.

In case you missed it, this week we had stories about medication adherence and breast cancer outcomes, new vaccines in the pipeline, independent pharmacies saying no to Medicare drug price, and more.

Acupuncture, a practice with thousands of years of history, has become increasingly accepted in mainstream medicine.

David Pope, PharmD, Chief Pharmacy Officer at XiFin, joined Drug Topics to discuss value-based care and how it has changed the way pharmacy operates.